EDGAR·FLOW

TuHURA Biosciences, Inc./NV — Form 8-K

Filed September 16, 2026 · analyzed by the 8-K Agent
8-K — Neutral significance 28/100
What the filing says
TuHURA Biosciences adopted a new 2026 Inducement Equity Incentive Plan on September 10, 2026, reserving 5,000,000 shares for issuance as employment inducement awards under Nasdaq Rule 5635(c)(4). The plan permits grants of options, restricted stock, RSUs, and other equity awards exclusively to new or returning employees as material inducements to employment, without requiring stockholder approval. Standard one-third annual vesting over three years applies to option grants under the plan.
Why this rating

Plan reserve (5M shares) is ~4.5% of typical public float; standard inducement plan adoption for hiring. No specific grants announced; routine administrative action for a $111M-cap biotech.

View original filing on SEC.gov ↗ HURA · stock on Yahoo Finance ↗

See more from September 16, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.